SCHEMBL8619953

SCHEMBL8619953

CCCc1ccc(Oc2ccc(C=CCC(P(=O)(OCC)OCC)S(=O)(=O)O)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 6/20 0.38
FDFT1 P37268 2/20 0.38
ACACB O00763 1/20 0.35
ACACA Q13085 1/20 0.35
THRB P10828 1/20 0.34
EED O75530 1/20 0.33
PTPN2 P17706 1/20 0.33
PTPN11 Q06124 1/20 0.33
S1PR1 P21453 1/20 0.32
S1PR3 Q99500 1/20 0.32
CYP4F2 P78329 1/20 0.32
CYP4A11 Q02928 1/20 0.32
PPARG P37231 1/20 0.32
PPARA Q07869 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8619951 1.00 PTPN1 (0.38) PTPN1FDFT1ACACBACACATHRB
SCHEMBL8624984 0.91 EED (0.40) FDFT1ACACBACACAEEDCYP4F2
SCHEMBL8624983 0.91 EED (0.40) FDFT1ACACBACACAEEDCYP4F2
SCHEMBL8624693 0.88 PTPN1 (0.40) PTPN1EEDPPARGALDH1A1LMNA
SCHEMBL8624698 0.88 PTPN1 (0.40) PTPN1EEDPPARGALDH1A1LMNA
SCHEMBL8625391 0.86 S1PR1 (0.41) S1PR1S1PR3
SCHEMBL8625397 0.86 S1PR1 (0.41) S1PR1S1PR3
SCHEMBL8625440 0.84 FDFT1 (0.40) FDFT1EEDS1PR1S1PR3KDM4E
SCHEMBL8625446 0.84 FDFT1 (0.40) FDFT1EEDS1PR1S1PR3KDM4E
SCHEMBL8624889 0.84 EED (0.39) EEDS1PR1S1PR3PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5712396-A PHOSPHONOSULFONATE COMPOUNDS USED FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND ATHEROSCLEROSIS MAGNIN DAVID R (US) 1998-01-27 US disclosed
US-5567841-A ANTICHOLESTEROL AGENT BRISTOL-MYERS SQUIBB COMPANY (US) 1996-10-22 US disclosed
US-5470845-A Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia BRISTOL-MYERS SQUIBB COMPANY (US) 1995-11-28 US disclosed
EP-0595635-A1 Alpha-phosphorous substituted sulfonate derivatives as squalene synthetase inhibitors E.R. Squibb & Sons, Inc. (US) 1994-05-04 EP disclosed